Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.

about

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.

Item

http://www.wikidata.org/entity/Q39610783

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Transthyretin familial amyloid ...... late- and early-onset disease.

@en

Transthyretin familial amyloid polyneuropathy

@nl

type

Item

label

Transthyretin familial amyloid ...... late- and early-onset disease.

@en

Transthyretin familial amyloid polyneuropathy

@nl

prefLabel

Transthyretin familial amyloid ...... late- and early-onset disease.

@en

Transthyretin familial amyloid polyneuropathy

@nl

P1476

Transthyretin familial amyloid ...... late- and early-onset disease

@en

P2093

Cristina Gallego-Lezaún

http://www.w3.org/2001/XMLSchema#string

Eugenia Cisneros-Barroso

http://www.w3.org/2001/XMLSchema#string

Hernán Andreu-Serra

http://www.w3.org/2001/XMLSchema#string

Juan Buades-Reinés

http://www.w3.org/2001/XMLSchema#string

Mercedes Usón-Martín

http://www.w3.org/2001/XMLSchema#string

Tomás Ripoll-Vera

http://www.w3.org/2001/XMLSchema#string

P2860

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.

Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.

Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families.

Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study.

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity.

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient.

Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.

P304

352-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JNS.12180

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Raya-Cruz

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27403623

http://www.w3.org/2001/XMLSchema#string